Expert led solutions

Experts test alignment among the scientific question, population, endpoints, estimand, operational feasibility and regulatory strategy. They challenge assumptions, compare alternatives, identify bias and variability risks, and recommend simulation or sensitivity analyses. Early cross-functional review also confirms the design can be implemented in the EDC, analyzed as planned and explained clearly in regulatory documents.

Medical monitoring provides physician oversight of participant safety and medically important study issues. Responsibilities include reviewing eligibility, adverse events, serious adverse events, laboratory trends, protocol deviations and investigator questions as defined in the monitoring plan. Bioforum’s medical monitors work across drug, device and combination studies. It is distinct from clinical monitoring, which focuses on site conduct and source verification.

Risk-based quality management is a proactive framework for identifying factors critical to quality, assessing risks, defining controls, monitoring signals and adapting oversight accordingly. Traditional monitoring emphasizes site verification after the fact. Bioforum implements RBQM through centralized analytics in BioGRID, supporting critical to quality factors, key risk indicators and quality tolerance limits, so signals surface from the data rather than at the next site visit.

Yes. Sponsors engage Bioforum experts for discrete needs including protocol design review, an independent statistical opinion, a regulatory response or preparation for an FDA or EMA meeting, as well as ongoing advisory roles. Scoping to the decision at hand keeps senior expertise accessible without committing to a full outsourcing arrangement.